Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial. (Record no. 20254688)

MARC details
000 -LEADER
fixed length control field 02428 a2200673 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516005040.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201011s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-547X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S0140-6736(10)61384-0
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Gane, Edward J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20101130
245 00 - TITLE STATEMENT
Title Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Lancet (London, England)
Date of publication, distribution, etc. Oct 2010
300 ## - PHYSICAL DESCRIPTION
Extent 1467-75 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclopropanes
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C, Chronic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon alpha-2
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-alpha
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isoindoles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactams
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactams, Macrocyclic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polyethylene Glycols
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proline
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element RNA, Viral
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Viral Nonstructural Proteins
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roberts, Stuart K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stedman, Catherine A M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Angus, Peter W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ritchie, Brett
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Elston, Rob
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ipe, David
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Morcos, Peter N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Baher, Linda
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Najera, Isabel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chu, Tom
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lopatin, Uri
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Berrey, M Michelle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bradford, William
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Laughlin, Mark
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shulman, Nancy S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Smith, Patrick F
773 0# - HOST ITEM ENTRY
Title Lancet (London, England)
Related parts vol. 376
-- no. 9751
-- p. 1467-75
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S0140-6736(10)61384-0">https://doi.org/10.1016/S0140-6736(10)61384-0</a>
Public note Available from publisher's website

No items available.